Results 201 to 210 of about 304,700 (295)

Type I and II Interferons Drive Abacavir Hypersensitivity via Treg Suppression and T‐Cell Enhancement in Immunocompetent HLA‐Transgenic Mice

Allergy, EarlyView.
Upregulated HLA‐B*57:01 expression in Tg/KO mice amplifies abacavir‐specific CD8+ T‐cell activation, driven by enhanced antigen presentation. Abacavir treatment induces robust pDC expansion and IFN‐α production, which selectively suppresses memory Treg populations.
SuJin Hwang, Telly Sepahpour, Stephanie Kortchak, Kirthiram Krishnaveni Sivakumar, Spyros Karaiskos, Ngoc Pham, Yura Jang, Montserrat Puig, Michael Norcross   +8 more
wiley   +1 more source

Infection control in the brain and the eye

Acta Ophthalmologica, EarlyView.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester, Paul G. McMenamin, Samantha J. Dando   +2 more
wiley   +1 more source

Risk Factors and Outcomes of Disseminated Nocardiosis Across Host Risk Groups. [PDF]

Open Forum Infect Dis
Vega Brizneda M, Miranda C, Cober E, Misra A, Harrington S, Yetmar ZA.   +5 more
europepmc   +1 more source

Tick‐Borne Encephalitis (TBE) Vaccine in the National Immunisation Programme—For Whom, When and Where?

Acta Paediatrica, EarlyView.
ABSTRACT The incidence of Tick‐borne encephalitis (TBE) cases has increased. The presumed location of transmission of Tick‐borne encephalitis virus (TBEV) has been expanding increasingly in the western parts of Europe during the past decade. There has also been an increased incidence of surveillance‐reported TBE cases in southern Sweden and southern ...
H. H. Askling, D. Zavadska
wiley   +1 more source

Sphingobacterium hotanense Infections in Immunocompromised Patients, United States. [PDF]

Emerg Infect Dis
Abu-Zeinah K, Lueck BD, Fuentes SA, Puumala E, Abu Saleh OM.   +4 more
europepmc   +1 more source

Morbidity and Mortality of Blood Stream Infections in Severely Burned Patients [PDF]

, 2009
Blot, Stijn, Brusselaers, Nele, Hoste, Eric, Monstrey, Stan, snoeij, t, Vogelaers, Dirk   +5 more
core   +1 more source

Rationale for Recommending Varicella Vaccination Into the Swedish National Immunisation Programme

Acta Paediatrica, EarlyView.
ABSTRACT Aim Under Swedish law, a vaccination may be included in the National Immunisation Programme (NIP) if it effectively prevents transmission in the population, is cost‐effective and aligns with ethical and humanitarian principles. The Public Health Agency of Sweden (PHAS) evaluated these criteria for introducing varicella vaccination. Methods The
Annika Ersson, Kari Johansen, Sören Andersson   +2 more
wiley   +1 more source

Clinical Case Report on the Use of Rezafungin in <i>Pneumocystis jirovecii</i> Pneumonia in a Critically Ill Patient. [PDF]

Microorganisms
Fernández-Fernández R, García-Martínez R, Fernández WS, Chueca-Porcuna N, Colmenero-Ruiz M.   +4 more
europepmc   +1 more source

Miltefosine in visceral leishmaniasis.

, 2003
Bryceson, Anthony DM, Engel, Jurgen, Olliaro, Piero L, Ridley, Robert G, Sindermann, Herbert   +4 more
core   +1 more source

Risk of SARS‐CoV‐2 Infection and Hospitalisation in Immunocompromised Children: A Population‐Based Cohort Study in Italy and Norway

Acta Paediatrica, EarlyView.
ABSTRACT Aim Immunocompromised children (IC) were presumed to be at higher risk of SARS‐COV‐2 infection and severe COVID‐19, but population‐based evidence is limited. We assessed infection risk, COVID‐19 hospitalisation, and severe outcomes in IC compared with children with and without other high‐risk conditions.
Costanza Di Chiara, Riccardo Boracchini, Nhung T. H. Trinh, Arianna Giugni, Giulia Sturniolo, Elisa Visonà, Ali Judd, Marthe Le Prevost, Claire Thorne, Pia Hardelid, Carlo Giaquinto, Angela Lupattelli, Daniele Donà, Anna Cantarutti   +13 more
wiley   +1 more source